Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Quantitative Research on Front of Package Labeling on Packaged Foods; Reopening of the Comment Period, 47886 [2023-15639]
Download as PDF
<![CDATA[
47886
Federal Register / Vol. 88, No. 141 / Tuesday, July 25, 2023 / Notices
Recipient
Award amount
Partnership for Trauma Recovery, Berkeley, California ......................................................................................................................
Program for Torture Victims LA County, Los Angeles, California ......................................................................................................
The Center for Victims of Torture, Atlanta, Georgia ...........................................................................................................................
The Center for Victims of Torture, St. Paul, Minnesota ......................................................................................................................
These programs will provide direct
services to the 222 Nicaraguan
Humanitarian Parolees (NHP) who were
released from prison in Nicaragua and
brought to the United States by the U.S.
Department of State in February 2023.
On February 16, 2023, ORR issued
Dear Colleague Letter 23–16, which
stated that while the NHP’s current
immigration status does not provide
eligibility for refugee program
assistance, they may apply for
assistance from ORR-funded Survivors
of Torture (SOT) grant recipients. ORR
has been working closely with the U.S.
Department of State to connect these
individuals to SOT grant recipients and
other local service providers. Due to the
nature and length of the NHP’s
detention in Nicaragua, their sudden
release from prison and entry into the
United States, and their temporary
immigration status, these individuals
need immediate assistance. The SOT
grant recipients identified above are
willing to provide medical, mental
health, case management, and legal
services to these individuals. However,
the timing of these arrivals and the
concentration in certain states has
overwhelmed the capacity of SOT grant
recipients in these locations. The
supplemental awards will enhance the
grant recipients’ capacity to provide
essential care and support for NHP so
that they can begin the healing process.
Statutory Authority: Section 5(a) of
the ‘‘Torture Victims Relief Act of
1998,’’ Public Law 105–320 (22 U.S.C.
2152 note) Assistance for Treatment of
Torture Victims.
Karen D. Shields,
Senior Grants Policy Specialist, Office of
Grants Policy, Office of Administration.
[FR Doc. 2023–15650 Filed 7–24–23; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4184–46–P
VerDate Sep<11>2014
18:12 Jul 24, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–0155]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Quantitative
Research on Front of Package
Labeling on Packaged Foods;
Reopening of the Comment Period
Food and Drug Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice; reopening of the
comment period.
AGENCY:
The Food and Drug
Administration (FDA or we) is
reopening the comment period for the
notice entitled ‘‘Agency Information
Collection Activities; Submission for
Office of Management and Budget
Review; Comment Request; Quantitative
Research on Front of Package Labeling
on Packaged Foods,’’ published in the
Federal Register of June 15, 2023, to
allow interested parties additional time
to submit comments. We are taking this
action due to technical difficulties
experienced on the final two days of the
comment period that may have
prevented some interested parties from
submitting comments.
DATES: FDA is reopening the comment
period on the notice published on June
15, 2023 (88 FR 39257). Submit written
comments (including recommendations)
on the collection of information by
11:59 p.m. on Wednesday, July 26,
2023.
SUMMARY:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRA/
icrPublicCommentRequest?ref_
nbr=202306-0910-004. You may also
find this particular information
collection at https://www.reginfo.gov/
public/do/PRAMain by following these
instructions: Under the header
‘‘Currently under Review Select
Agency’’ use the drop down menu to
select ‘‘Department of Health and
Human Services’’ or by using the search
function. The title of this information
ADDRESSES:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
30,000
20,000
$3,000
70,000
collection is ‘‘Quantitative Research on
Front of Package Labeling on Packaged
Foods.’’ Also include the FDA docket
number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
JonnaLynn Capezzuto, Office of
Operations, Food and Drug
Administration, Three White Flint
North, 10A–12M, 11601 Landsdown St.,
North Bethesda, MD 20852, 301–796–
3794, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of June 15, 2023 (88 FR
39257), FDA announced that a proposed
collection of information had been
submitted to the Office of Management
and Budget for review and clearance
under the Paperwork Reduction Act of
1995. Interested parties were originally
given until July 17, 2023, to submit
comments (including recommendations)
on the information collection.
However, on July 16 and 17, 2023,
technical difficulties may have
prevented some stakeholders from
submitting electronic comments.
Therefore, we are reopening the
comment period to allow interested
parties additional time to submit
comments. The reopened comment
period provides an opportunity for
stakeholders who may have been
impacted by the technical difficulties.
Dated: July 19, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–15639 Filed 7–24–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2022–D–0055 and FDA–
2020–N–1790]
M7(R2) Assessment and Control of
Deoxyribonucleic Acid Reactive
(Mutagenic) Impurities in
Pharmaceuticals To Limit Potential
Carcinogenic Risk, M7(R2) Addendum,
and M7(R2) Questions and Answers;
International Council for
Harmonisation; Guidances for
Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
E:\FR\FM\25JYN1.SGM
25JYN1
]]>Agencies
[Federal Register Volume 88, Number 141 (Tuesday, July 25, 2023)]
[Notices]
[Page 47886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15639]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-0155]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Quantitative Research
on Front of Package Labeling on Packaged Foods; Reopening of the
Comment Period
AGENCY: Food and Drug Administration, Department of Health and Human
Services (HHS).
ACTION: Notice; reopening of the comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is reopening the
comment period for the notice entitled ``Agency Information Collection
Activities; Submission for Office of Management and Budget Review;
Comment Request; Quantitative Research on Front of Package Labeling on
Packaged Foods,'' published in the Federal Register of June 15, 2023,
to allow interested parties additional time to submit comments. We are
taking this action due to technical difficulties experienced on the
final two days of the comment period that may have prevented some
interested parties from submitting comments.
DATES: FDA is reopening the comment period on the notice published on
June 15, 2023 (88 FR 39257). Submit written comments (including
recommendations) on the collection of information by 11:59 p.m. on
Wednesday, July 26, 2023.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRA/icrPublicCommentRequest?ref_nbr=202306-0910-004. You may also find this particular information collection at
https://www.reginfo.gov/public/do/PRAMain by following these
instructions: Under the header ``Currently under Review Select Agency''
use the drop down menu to select ``Department of Health and Human
Services'' or by using the search function. The title of this
information collection is ``Quantitative Research on Front of Package
Labeling on Packaged Foods.'' Also include the FDA docket number found
in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
[email protected].
SUPPLEMENTARY INFORMATION: In the Federal Register of June 15, 2023 (88
FR 39257), FDA announced that a proposed collection of information had
been submitted to the Office of Management and Budget for review and
clearance under the Paperwork Reduction Act of 1995. Interested parties
were originally given until July 17, 2023, to submit comments
(including recommendations) on the information collection.
However, on July 16 and 17, 2023, technical difficulties may have
prevented some stakeholders from submitting electronic comments.
Therefore, we are reopening the comment period to allow interested
parties additional time to submit comments. The reopened comment period
provides an opportunity for stakeholders who may have been impacted by
the technical difficulties.
Dated: July 19, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-15639 Filed 7-24-23; 8:45 am]
BILLING CODE 4164-01-P
